P
US10174308B2ActiveUtilityPatentIndex 34

Successive capture of nucleic acid by magnetic glass particles

Assignee: ROCHE MOLECULAR SYSTEMS INCPriority: Jan 5, 2016Filed: Jan 4, 2017Granted: Jan 8, 2019
Est. expiryJan 5, 2036(~9.5 yrs left)· nominal 20-yr term from priority
Inventors:CASILLA ALANGriswold JenniferHOLCOMB CHERIEHryce TrevorKAMPANI KARANLegaspi Sharon
C07H 21/00C12N 15/1013C12Q 1/6806C12Q 2563/149C12Q 2563/143
34
PatentIndex Score
0
Cited by
9
References
17
Claims

Abstract

Provided herein are methods and components for successive capture of nucleic acids using magnetic glass particles.

Claims

exact text as granted — not AI-modified
What is claimed: 
     
       1. A method for capturing nucleic acids in a liquid sample comprising:
 (a) contacting a first aliquot of the liquid sample with magnetic glass particles (MGPs) in a vessel under conditions that allow nucleic acids from the liquid sample to non-covalently bind to MGPs, wherein the MGPs are non-porous and comprise at least one ferromagnetic magnetic core in glass; 
 (b) applying a magnetic field to the MGPs; 
 (c) removing unbound liquid sample from the MGPs; 
 (d) contacting a second aliquot of the liquid sample with the MGPs; 
 (e) resuspending the MGPs in the second aliquot of the liquid sample; 
 (f) pipetting the MGPs to the top of the second aliquot and dispensing the MGPs; 
 (g) applying a magnetic field to the MGPs to form a clump of MGPs; 
 (h) removing unbound liquid sample from the clump of MGPs; and 
 (i) optionally repeating steps (d) through (h) for at least one additional aliquot of liquid sample. 
 
     
     
       2. The method of  claim 1 , wherein the MGPs have a mean diameter between 0.5-15 μm. 
     
     
       3. The method of  claim 1 , wherein the glass comprises at least one metal oxide. 
     
     
       4. The method of  claim 3 , wherein the at least one metal oxide is selected from SiO 2 , B 2 O 3 , Al 2 O 3 , K 2 O, CaO, and ZnO. 
     
     
       5. The method of  claim 3 , wherein the liquid sample is blood, plasma, serum, urine, or a lysate thereof. 
     
     
       6. The method of  claim 3 , wherein the liquid sample has a volume of at least 2 ml. 
     
     
       7. The method of  claim 6 , wherein the liquid sample has a volume of 2 ml to 100 ml. 
     
     
       8. The method of  claim 6 , wherein the vessel holds a volume of 2 ml or less. 
     
     
       9. The method of  claim 6 , wherein the vessel holds a volume of 0.5 ml to 2 ml. 
     
     
       10. The method of  claim 6 , further comprising eluting and separating the nucleic acids from the MGPs. 
     
     
       11. The method of  claim 6 , wherein the method is automated. 
     
     
       12. The method of  claim 6 , wherein step (e) comprises pipetting the MGPs in the liquid sample. 
     
     
       13. The method of  claim 6 , wherein the nucleic acids are RNA. 
     
     
       14. The method of  claim 6 , wherein the nucleic acids are DNA. 
     
     
       15. The method of  claim 6 , wherein the vessel is a well in a multi-well plate or a tube. 
     
     
       16. The method of  claim 6 , wherein step (c) comprises removing unbound liquid sample from the MGPs, washing the MGPs, and removing unbound material from the MGPs. 
     
     
       17. The method of  claim 6 , wherein step (h) comprises removing unbound liquid sample from the MGPs, washing the MGPs, and removing unbound material from the MGPs.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.